CAJ | 학술논문

目的:探究应用莫西沙星联合依替米星对耐多药肺结核的临床疗效.方法:选取近两年在我院接受治疗的耐多药肺结核患者92例,随机分两组,各46人,分别为试验组、对照组,在常规治疗基础上,对照组联合左氧氟沙星治疗,试验组进行莫西沙星联合依替米星治疗,观察并比较两组患者经不同治疗方式后的治疗有效率情况.结果:试验组治疗后的总有效率(91.30%)明显高于对照组治疗后的总有效率(63.04%),具有统计学意义(P<0.05).结论:采用莫西沙星联合依替米星治疗耐多药肺结核的患者症状改善更显著.
목적:탐구응용막서사성연합의체미성대내다약폐결핵적림상료효.방법:선취근량년재아원접수치료적내다약폐결핵환자92례,수궤분량조,각46인,분별위시험조、대조조,재상규치료기출상,대조조연합좌양불사성치료,시험조진행막서사성연합의체미성치료,관찰병비교량조환자경불동치료방식후적치료유효솔정황.결과:시험조치료후적총유효솔(91.30%)명현고우대조조치료후적총유효솔(63.04%),구유통계학의의(P<0.05).결론:채용막서사성연합의체미성치료내다약폐결핵적환자증상개선경현저.
Objective To explore the application of moxifloxacin combined with clinical efficacy of etimicin on multi drug resistant pulmonary tuberculosis.Methods The experimental group of moxifloxacin joint etidronate M star treatment, were observed and compared between the two groups of patients after different treatment modalities of treatment effective rate.Results The total effective rate (91.30%) of the experimental group was significantly higher than that of the control group (63.04%), with statistical significance (P<0.05).Conclusion Combined with symptoms of netilmicin in treatment of multi drug resistant pulmonary tuberculosis patients were significantly improved by moxifloxacin.